Worth the Price?

The price tag of gene therapies could push $1 million, according to Kaiser Health News.

Novartis has priced its recently approved gene therapy, Kymriah, at $475,000. Kymriah, a CAR T-cell therapy, is the first approved gene therapy in the US.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.